文献速递皮肤肿瘤

美国黑色素瘤预后:识别改善诊疗的障碍

Melanoma prognosis in the United States: Identifying barriers for improved care.
PubMed 文献 · J Am Acad Dermatol · 2019-01-17

该研究基于1999至2014年美国癌症统计数据,以州为单位计算黑色素瘤死亡率与发病率比值(MIR),分析其与社会人口学和医疗保健因素的关联。多变量分析显示,活跃医师更多(P=.02)和非西班牙裔白人比例更高(P=.004)的州MIR更高(生存更差);高发病率和皮肤科医生密度较高地区的生存有所改善。

要点

  • 各州平均总体MIR为0.15±0.04,仅阿拉斯加为离群值(0.24)。
  • 多数州MIR随时间下降,无任何州MIR显著上升。
  • 活跃医师更多(P=.02)和非西班牙裔白人比例更高(P=.004)的州MIR更高,即生存更差。

核心结论

  • 高发病率地区和皮肤科医生密度较高地区的黑色素瘤生存有所改善,这些发现凸显了黑色素瘤生存较差的地区以及开展本地研究评估生存差异的必要性。

研究设计与样本

  • 利用1999至2014年美国癌症统计数据进行州级黑色素瘤死亡率与发病率比值(MIR)计算,采用Pearson相关和线性回归分析MIR与皮肤科医生密度、初级保健提供者密度、各州医生数量、美国国家癌症研究所指定癌症中心数量、人均医疗支出、平均家庭收入、种族/民族构成、无保险个人百分比及拥有学士学位百分比之间的关联。

主要发现

  • 平均总体MIR为0.15±0.04,仅阿拉斯加为离群值(0.24);无任何州MIR随时间显著上升,多数州MIR下降。
  • 多变量分析显示,活跃医师更多的州(P=.02)和非西班牙裔白人比例更高的州(P=.004)MIR更高(生存更差)。
  • Pearson相关分析显示,MIR与黑色素瘤发病率(r=-0.72,P<.001)、黑色素瘤死亡率(r=0.38,P<.001)、皮肤科医生密度(r=0.32,P<.001)及美国国家癌症研究所指定癌症中心数量(r=-0.12,P=.001)存在显著相关。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Despite improvements in melanoma mortality, disparities in melanoma survival persist. We evaluated possible sociodemographic and health care-based predictors of differences in melanoma survival in the United States by using the melanoma mortality-to-incidence ratio (MIR). METHODS: State-based MIRs were calculated by using US cancer statistics data from 1999 to 2014. Pearson correlations and linear regressions were used to determine associations between MIR and dermatologist density, primary care provider density, number of physicians by state, number of National Cancer Institute-designated cancer centers, health care spending per capita, average household income, racial/ethnic makeup of the population, percentage of uninsured individuals, and percentage with a bachelor's degree. RESULTS: The mean overall MIR was 0.15 ± 0.04; only Alaska was an outlier (0.24). No state MIRs increased significantly over time; MIR decreased for most states. Multivariable analysis revealed that states with more active physicians (P = .02) and a higher percentage non-Hispanic whites (P = .004) had higher MIRs (poorer survival). Significant Pearson correlations were seen between MIR and melanoma incidence (r = -0.72, P < .001), melanoma mortality (r = 0.38, P < .001), dermatologist density (r = 0.32, P < .001), and National Cancer Institute-designated cancer center count (r = -0.12, P = .001). CONCLUSIONS: Melanoma survival is improved in higher-incidence areas and areas with higher dermatologist density. These findings highlight areas of poorer melanoma survival and the need for local studies evaluating disparities in melanoma survival.

来源:J Am Acad Dermatol,查看原文。版权归原作者所有。

引用

  1. Hopkins ZH, Moreno C, Carlisle R, et al. Melanoma prognosis in the United States: Identifying barriers for improved care. J Am Acad Dermatol. 2019. PMID: 30659870. doi:10.1016/j.jaad.2019.01.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。